|
Lumos Pharma, Inc.
Ticker Symbol: LUMO CUSIP: 55028X109 Previous CUSIP: 651511107 Exchange: NGM
Company's Online Profile
BUSINESS: Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases.
|
IPO - 11/15/2011 - 6.20 Million Shares @ $7.00/share.
Link to IPO Prospectus
Previous Ticker Symbol: NLNK Changed: 3/18/20
Previous Name: NewLink Genetics Corp.
Micro Cap Stock -
Market Value $ 71.1 Million
Click for current LUMO price quote from the NASDAQ
Yahoo News Summary for LUMO
YAHOO! Profile for LUMO
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for LUMO
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 4200 Marathon Blvd., Suite 200, Austin, TX 78756 |
| Main Phone Number |
515-215-2630 |
| Fax Number |
515-296-5557 |
| Investor Relations
|
512-648-3757
|
Toll Free Phone Number |
Unknown |
| CEO - Rick Hawkins |
CFO - Lori Lawley |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
